StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note issued to investors on Sunday morning. The firm issued a hold rating on the stock.
China Pharma Price Performance
Shares of CPHI opened at $0.21 on Friday. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. The firm has a fifty day simple moving average of $0.22 and a two-hundred day simple moving average of $0.23. China Pharma has a 1-year low of $0.17 and a 1-year high of $0.69.
About China Pharma
Recommended Stories
- Five stocks we like better than China Pharma
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Why Are These Companies Considered Blue Chips?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.